PL376470A1 - Sposób leczenia zespołu X za pomocą podstawionychtetralin i indanów - Google Patents
Sposób leczenia zespołu X za pomocą podstawionychtetralin i indanówInfo
- Publication number
- PL376470A1 PL376470A1 PL03376470A PL37647003A PL376470A1 PL 376470 A1 PL376470 A1 PL 376470A1 PL 03376470 A PL03376470 A PL 03376470A PL 37647003 A PL37647003 A PL 37647003A PL 376470 A1 PL376470 A1 PL 376470A1
- Authority
- PL
- Poland
- Prior art keywords
- indanes
- treating syndrome
- substituted tetralins
- tetralins
- substituted
- Prior art date
Links
- 125000003392 indanyl group Chemical class C1(CCC2=CC=CC=C12)* 0.000 title 1
- 208000011580 syndromic disease Diseases 0.000 title 1
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
- C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C333/02—Monothiocarbamic acids; Derivatives thereof
- C07C333/08—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41992702P | 2002-10-21 | 2002-10-21 | |
| US49575803P | 2003-08-15 | 2003-08-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376470A1 true PL376470A1 (pl) | 2005-12-27 |
Family
ID=32179770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03376470A PL376470A1 (pl) | 2002-10-21 | 2003-10-17 | Sposób leczenia zespołu X za pomocą podstawionychtetralin i indanów |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20040162352A1 (pl) |
| EP (1) | EP1556344A1 (pl) |
| JP (1) | JP2006503915A (pl) |
| KR (1) | KR20050067419A (pl) |
| AU (1) | AU2003279981A1 (pl) |
| BR (1) | BR0315566A (pl) |
| CA (1) | CA2503405A1 (pl) |
| CO (1) | CO5690541A2 (pl) |
| EA (1) | EA200500517A1 (pl) |
| HR (1) | HRP20050337A2 (pl) |
| MX (1) | MXPA05004296A (pl) |
| NO (1) | NO20052277L (pl) |
| NZ (1) | NZ539432A (pl) |
| PL (1) | PL376470A1 (pl) |
| RS (1) | RS20050319A (pl) |
| TW (1) | TW200412935A (pl) |
| WO (1) | WO2004037777A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003279996B2 (en) * | 2002-10-21 | 2009-07-09 | Janssen Pharmaceutica, N.V. | Substituted tetralins and indanes and their use |
| KR20050055773A (ko) * | 2002-10-21 | 2005-06-13 | 얀센 파마슈티카 엔.브이. | 치환된 테트라린 및 인단 |
| SG146692A1 (en) | 2003-10-01 | 2008-10-30 | Procter & Gamble | Melanin concentrating hormone antagonists |
| AR048931A1 (es) * | 2004-04-21 | 2006-06-14 | Janssen Pharmaceutica Nv | Proceso para la preparacion de derivados de tetralina sustituida e indano sustituido y preparacion de intermediarios de sintesis |
| JP4619413B2 (ja) * | 2004-10-12 | 2011-01-26 | ファーマコペイア ドラッグ ディスカバリー, インコーポレイテッド | 肥満および関連障害の処置のための選択的メラニン濃縮ホルモンレセプターアンタゴニストとしての二環式化合物 |
| US20060263450A1 (en) * | 2005-05-17 | 2006-11-23 | Julius Oben | Method and composition for reducing body weight and improving control of body lipids |
| FR2896160B1 (fr) * | 2006-01-13 | 2008-04-25 | Merck Sante Soc Par Actions Si | Combinaison de derives de triazine et d'agonistes du ppar alpha. |
| US20100098793A1 (en) * | 2008-10-17 | 2010-04-22 | Gateway Health Alliances, Inc. | Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing adiponectin levels |
| US20100098792A1 (en) * | 2008-10-17 | 2010-04-22 | Gateway Health Alliances, Inc. | Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglycerides levels and increase adiponectin levels |
| US20130203769A1 (en) * | 2012-02-08 | 2013-08-08 | University Of Cincinnati | Targeting Metabolic Adaptive Responses to Chemotherapy |
| CN107406369B (zh) | 2014-12-09 | 2021-01-15 | 以西结·戈兰 | 放纵行为调节剂 |
| US11528924B2 (en) | 2014-12-09 | 2022-12-20 | Clearmind Medicine, Inc. | Alcoholic beverage substitutes |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU632809B2 (en) * | 1989-05-25 | 1993-01-14 | Takeda Chemical Industries Ltd. | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof |
| GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| GB9822473D0 (en) * | 1998-10-16 | 1998-12-09 | Glaxo Group Ltd | Chemical compounds |
| JP2003523336A (ja) * | 2000-02-18 | 2003-08-05 | メルク エンド カムパニー インコーポレーテッド | 糖尿病及び脂質障害のためのアリールオキシ酢酸 |
| HUP0302306A3 (en) * | 2000-10-05 | 2005-02-28 | Bayer Ag | Propionic acid derivatives with ppar-alpha activating properties |
| WO2002044129A1 (fr) * | 2000-11-29 | 2002-06-06 | Kyorin Pharmaceutical Co., Ltd. | Dérivés d'acide carboxylique substitués |
| WO2002046146A1 (fr) * | 2000-12-05 | 2002-06-13 | Kyorin Pharmaceutical Co., Ltd. | Derives d'acide carboxylique substitues |
| AU2002233271A1 (en) * | 2000-12-20 | 2002-07-01 | Glaxo Group Limited | Substitued oxazoles and thiazoles as hppar alpha agonists |
| US6548538B2 (en) * | 2001-05-22 | 2003-04-15 | Bayer Aktiengesellschaft | Propionic acid derivatives |
| AU2002319627A1 (en) * | 2001-07-20 | 2003-03-03 | Merck And Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
| UA82835C2 (en) * | 2001-12-03 | 2008-05-26 | Reddys Lab Ltd Dr | ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon |
| KR20050055773A (ko) * | 2002-10-21 | 2005-06-13 | 얀센 파마슈티카 엔.브이. | 치환된 테트라린 및 인단 |
| AU2003279996B2 (en) * | 2002-10-21 | 2009-07-09 | Janssen Pharmaceutica, N.V. | Substituted tetralins and indanes and their use |
-
2003
- 2003-10-17 CA CA002503405A patent/CA2503405A1/en not_active Abandoned
- 2003-10-17 MX MXPA05004296A patent/MXPA05004296A/es not_active Application Discontinuation
- 2003-10-17 EP EP03773286A patent/EP1556344A1/en not_active Withdrawn
- 2003-10-17 US US10/688,572 patent/US20040162352A1/en not_active Abandoned
- 2003-10-17 EA EA200500517A patent/EA200500517A1/ru unknown
- 2003-10-17 RS YUP-2005/0319A patent/RS20050319A/sr unknown
- 2003-10-17 WO PCT/US2003/033088 patent/WO2004037777A1/en not_active Ceased
- 2003-10-17 US US10/688,380 patent/US20040171680A1/en not_active Abandoned
- 2003-10-17 NZ NZ539432A patent/NZ539432A/en not_active IP Right Cessation
- 2003-10-17 KR KR1020057006798A patent/KR20050067419A/ko not_active Withdrawn
- 2003-10-17 HR HR20050337A patent/HRP20050337A2/hr not_active Application Discontinuation
- 2003-10-17 JP JP2005501628A patent/JP2006503915A/ja not_active Withdrawn
- 2003-10-17 PL PL03376470A patent/PL376470A1/pl not_active Application Discontinuation
- 2003-10-17 BR BR0315566-8A patent/BR0315566A/pt not_active IP Right Cessation
- 2003-10-17 AU AU2003279981A patent/AU2003279981A1/en not_active Abandoned
- 2003-10-21 TW TW092129194A patent/TW200412935A/zh unknown
-
2005
- 2005-05-10 NO NO20052277A patent/NO20052277L/no unknown
- 2005-05-20 CO CO05048979A patent/CO5690541A2/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| TW200412935A (en) | 2004-08-01 |
| NZ539432A (en) | 2008-04-30 |
| BR0315566A (pt) | 2005-08-23 |
| WO2004037777A1 (en) | 2004-05-06 |
| EP1556344A1 (en) | 2005-07-27 |
| JP2006503915A (ja) | 2006-02-02 |
| US20040171680A1 (en) | 2004-09-02 |
| MXPA05004296A (es) | 2005-11-23 |
| HRP20050337A2 (en) | 2005-12-31 |
| NO20052277L (no) | 2005-06-29 |
| CA2503405A1 (en) | 2004-05-06 |
| NO20052277D0 (no) | 2005-05-10 |
| EA200500517A1 (ru) | 2005-10-27 |
| RS20050319A (sr) | 2007-09-21 |
| US20040162352A1 (en) | 2004-08-19 |
| AU2003279981A1 (en) | 2004-05-13 |
| CO5690541A2 (es) | 2006-10-31 |
| KR20050067419A (ko) | 2005-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI348329B (en) | Electroluminescent devices and their manufacture | |
| TWI340606B (en) | Polymer compound and polymer luminous element using the same | |
| AU2003270341A8 (en) | Modified asialo-interferons and uses thereof | |
| AU2003256217A8 (en) | New polymers and applications | |
| AU2002327874A8 (en) | Antenna with one or more holes | |
| IL166377A0 (en) | Vrgfr-2 and vgefr-3 inhibitory and anthranylamidpyrimidines | |
| HU0301063D0 (en) | Benzoic-acid isononylesters and applying them | |
| EG25097A (en) | Piprazinyl and diazapanyl benzamides and benzthioamides. | |
| PL372970A1 (pl) | Element mocujący i układ mocujący | |
| PL376470A1 (pl) | Sposób leczenia zespołu X za pomocą podstawionychtetralin i indanów | |
| AU2003290341A8 (en) | Electroluminescent materials and devices | |
| GB0228335D0 (en) | Electroluminescent materials and devices | |
| AU2003215257A8 (en) | Modified defensins and their use | |
| GB0226408D0 (en) | Catalyst and process | |
| AU2003291087A8 (en) | Ionene oligomers and polymers | |
| GB0200365D0 (en) | Software installation and operation | |
| EG24842A (en) | Substituted tetralins and indanes | |
| AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
| GB0228268D0 (en) | Catalyst and process | |
| AU2003228355A8 (en) | Adipocytes and uses thereof | |
| AU2003302173A8 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
| HK1078847A (en) | Treating syndrome x with substituted tetralins and indanes | |
| GB0228525D0 (en) | Polymers and their use | |
| GB2407324B (en) | Electroluminescent materials and devices | |
| AU2003286389A8 (en) | Ace-inhibitors having antioxidant and nitricoxid-donor activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |